Innoskel develops therapies designed for rare skeletal diseases.
Automatic translation

Activity area

  • MEDTECH
  • HEALTHTECH
  • PHARMATECH
  • CLINIC
  • BIOTECH

Maturity stage

  • Early bird

Key information

Year of creation

2020

Workforce

< 10

Maturity stage

Early bird

Total fundraising amount

20 000 000 €

Last round table level